2022

• January

  AllCheck COVID19 Ag, MFDS listed

• May

  AllCheck COVID-19 Antigen Self-Test, obtained CE Mark

• JULY

  AllCheck COVID19 Ag and AllCheck COVID19 Ag Nasal, listed in EU Common list

• October

  Investment : USD 1.4M

2021

• January

  Investment : USD 7M

• May

  Factory establishment in Gunpo-si

• June

  Selected for R&D project by the Ministry of SMEs and Stratups

• October

  Launched Influneza immunodiagnostic reagent

  · AllCheck Influenza A+B

• November

  KONEX listed

2020

• January

  Acquired the biosafety research facility level 2

• May

  Launched COVID-19 immunodiagnostic reagent

  · AllCheck COVID-19 IgG/IgM

  Investment : USD 2.3M

  Acquired ISO13485 Certificate (TÜV SÜD)

• June

  Selected for 2nd step of “Collabo R&D Project” by the Ministry of SMEs and Startups

• October

  Launched COVID-19 immunodiagnostic reagent

  · AllCheck COVID19 Ag

2019

• May

  Investment : USD 3M

• June

  Selected for “Collabo R&D Project” by the Ministry of SMEs and Startups

• August

  Acquired immunodiagnostics division from GenematrixBio

  Investment : USD 0.5M

• October

  Acquired KGMP certificate

  Listed a medical device manufacturer to MFDS

2018

• March

  Establishment of CALTH Inc.

• April

  Acquired exclusive license for ICP technology

• May

  Investment : USD 0.2M

• July

  Selected for R&D project by the Ministry of SMEs and Startups

• September

  Certified as a venture company

• November

  Certified as a Corporate R&D Center